Impact of clopidogrel in coronary artery bypass grafting

European Journal of Cardio-thoracic Surgery

Volumn 26, Issue 1, 2004, Pages 96-101

  Englberger, Lars ^a   Faeh, Bettina ^a   Berdat, Pascal A ^a   Eberli, Franz ^a   Meier, Bernhard ^a   Carrel, Thierry ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antiplatelet therapy; Blood loss; Clopidogrel; Coronary artery bypass grafting; Transfusion requirements

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APROTININ; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FRESH FROZEN PLASMA; HEPARIN;

ADULT; AGED; ANGINA PECTORIS; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; EMERGENCY SURGERY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VALVE SURGERY; HEMOSTASIS; HUMAN; INTRACARDIAC THROMBOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; PREVALENCE; PRIORITY JOURNAL; THORAX DRAINAGE; THROMBOCYTE TRANSFUSION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; CHEST TUBES; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; REOPERATION; TICLOPIDINE; TREATMENT OUTCOME;

EID: 2942598308     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.03.030     Document Type: Conference Paper

References (23)

1. Quinn M.J., Fitzgerald D.J. Ticlopidine and clopidogrel. Circulation. 100:1999;1667-1672
2. Taniuchi M., Kurz H.I., Lasala J.M. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad population. Circulation. 104:2001;539-543
3. Müller C., Buttner H.J., Petersen J., Roskamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation. 101:2000;590-593
4. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndrome without ST-segment elevation. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. N Engl J Med. 345:2001;494-502
5. Moshfegh K., Redondo M., Julmy F., Wuillemin W.A., Gebauer M.U., Haeberli A., Meyer B.J. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol. 36:2000;699-705
6. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet. 348:1996;1329-1339
7. Edmunds L.H. Hemostatic problems in surgical patients. Colman R.W., Hirsh J., Marder V.J. Hemostasis and thrombosis: basic principles and clinical practice. 4th ed. 2001;956-968
8. Levy J.H., Smith P.K. Platelet inhibitors and cardiac surgery. Ann Thorac Surg. 70:2000;S1-S2
9. Patrono C. Antiplatelet strategies. Eur Heart J. 4:2002;A49-A57
10. Steinhubl S.R. Antiplatelet agents in cardiology: the choice of therapy. Ann Thorac Surg. 70:2000;S3-S8
11. Levy J.H. Platelet inhibitors and bleeding in cardiac surgical patients. Ann Thorac Surg. 70:2000;S9-S11
12. Mochizuki T., Olson P.J., Szlam F., Ramsay J.G., Levy J.H. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 87:1998;781-785
13. Gansera B., Schmidtler F., Spiliopoulos K., Angelis I., Neumaier-Prauser P., Kemkes B.M. Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy. Thorac Cardiovasc Surgeon. 51:2003;185-189
14. Yende S., Wunderink R.G. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med. 29:2001;2271-2275
15. Hongo R.H., Ley J., Dick S.E., Yee R.R. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol. 40:2002;231-237
16. D'Ancona G., Donias H.W., Karamanoukian R.L., Bergsland J., Karamanoukian H.L. OPCAB therapy survey: off-pump clopidogrel, aspirin or both therapy survey. Heart Surg Forum. 4:2001;354-358
17. Essell J.H., Martin T.J., Salinas J., Thompson J.M., Smith V.C. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 7:1993;410-415
18. Mitka M. Results of CURE trial for acute coronary syndrome. J Am Med Assoc. 285:2001;1828-1829
19. Bhatt D.L., Chew D.P., Hirsch A.T., Ringleb P.A., Hacke W., Topol E.J. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation. 103:2001;363-368
20. Ley S.J. Quality care outcomes in cardiac surgery: the role of evidence-based practice. AACN Clin Issues. 12:2001;606-617
21. Munoz J.J., Birkmeyer N.J., Dacey L.J., Birkmeyer J.D., Charlesworth D.C., Johnson E.R., Lahey S.J., Norotsky M., Quinn R.D., Westbrook B.M., O'Connor G.T. Trends in rates of reexploration for hemorrhage after coronary artery bypass surgery. Northern New England Cardiovascular Disease study Group. Ann Thorac Surg. 68:1999;1321-1325
22. Tuman K.J., McCarthy R.J., O'Connor C.J., McCarthy W.E., Ivankovich A.D. Aspirin does not increase allogenic blood transfusion in reoperative coronary artery surgery. Anesth Analg. 83:1996;1178-1184
23. Herbert J.M., Bernat A., Maffrand J.P. Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat. Thromb Res. 71:1993;443-451